HCFA Officials Seek To Protect Local Coverage Review Flexibility
This article was originally published in The Gray Sheet
Executive Summary
The ongoing reform of the Health Care Financing Administration's coverage review process should preserve the ability of Medicare carriers to develop local policy, according to HCFA Administrator Nancy-Ann DeParle.
You may also be interested in...
Reimbursement, Sales Critical For IPOs As Markets Reopen To Device Firms
"Reimbursement clarity" is essential for device firms in gaining investor confidence in the public equity market, Jeffrey Hoffman, health technology investment banker with U.S. Bancorp Piper Jaffray, emphasized at the recent Frost & Sullivan 5th Annual Medical Devices and Diagnostics Industry Conference in San Francisco.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.